Literature DB >> 3179802

Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study.

W P Castelli1.   

Abstract

The USA is about to launch a massive campaign to identify those members of the population at risk for coronary artery disease (CAD). A screening process based on the high blood pressure campaign started in the 1970s aims at identifying those people with elevated cholesterol so measures can be taken to prevent fatal or nonfatal heart attacks. Data from 35 years of the Framingham Heart Study have shown that factors other than total or low density lipoprotein (LDL) cholesterol must be considered when evaluating CAD risk. In fact low levels of high density lipoprotein (HDL) cholesterol are as much a risk factor for CAD as high LDL cholesterol. The best simple test for predicting CAD is the ratio of total:HDL cholesterol and using this criterion, approximately half the population of North America is at risk for heart attack. This highlights the necessity for a screening program of cholesterol levels, and as there are tests available which can measure cholesterol in under 10 mins, the time should soon be here that everyone knows their CAD risk.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179802

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  120 in total

1.  Association between ABCG1 polymorphism rs1893590 and high-density lipoprotein (HDL) in an asymptomatic Brazilian population.

Authors:  V H S Zago; D Z Scherrer; E S Parra; N B Panzoldo; F Alexandre; E R Nakandakare; E C R Quintão; E C de Faria
Journal:  Mol Biol Rep       Date:  2014-11-15       Impact factor: 2.316

2.  Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.

Authors:  Samia Mora; Julie E Buring; Paul M Ridker; Yadong Cui
Journal:  Ann Intern Med       Date:  2011-12-06       Impact factor: 25.391

Review 3.  High-density lipoprotein subfractions and risk of coronary artery disease.

Authors:  John Morgan; Christina Carey; Anne Lincoff; David Capuzzi
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

4.  Chemical pathology and the new contract for GPs.

Authors:  P J Twomey; A S Wierzbicki; T M Reynolds
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

5.  Utility of dried blood spots for measurement of cholesterol and triglycerides in a surveillance study.

Authors:  Ramakrishnan Lakshmy; Ruby Gupta; Dorairaj Prabhakaran; Uma Snehi; K Srinath Reddy
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

Review 6.  Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review.

Authors:  C Roger White; David W Garber; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2014-08-25       Impact factor: 5.922

7.  Eating carbohydrate mostly at lunch and protein mostly at dinner within a covert hypocaloric diet influences morning glucose homeostasis in overweight/obese men.

Authors:  Raquel Duarte Moreira Alves; Fernanda Cristina Esteves de Oliveira; Helen Hermana Miranda Hermsdorff; Itziar Abete; María Angeles Zulet; José Alfredo Martínez; Josefina Bressan
Journal:  Eur J Nutr       Date:  2013-02-07       Impact factor: 5.614

Review 8.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

9.  Resveratrol, wine, and atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2012-03

10.  Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).

Authors:  C Roger White; Geeta Datta; Paulina Mochon; Zhenghao Zhang; Ollie Kelly; Christine Curcio; Dale Parks; Mayakonda Palgunachari; Shaila Handattu; Himanshu Gupta; David W Garber; G M Anantharamaiah
Journal:  Vasc Dis Prev       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.